David A. Siegel Artivion, Inc. Call Options Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AORT
# of Institutions
151Shares Held
34.9MCall Options Held
18KPut Options Held
1.5K-
Black Rock Inc. New York, NY6.74MShares$173 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.8MShares$71.8 Million0.07% of portfolio
-
Perceptive Advisors LLC New York, NY2.67MShares$68.5 Million1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.66MShares$68.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.34MShares$59.9 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.03B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...